» Articles » PMID: 26656852

A Method for Reproducible Measurements of Serum BDNF: Comparison of the Performance of Six Commercial Assays

Overview
Journal Sci Rep
Specialty Science
Date 2015 Dec 15
PMID 26656852
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-Derived Neurotrophic Factor (BDNF) has attracted increasing interest as potential biomarker to support the diagnosis or monitor the efficacy of therapies in brain disorders. Circulating BDNF can be measured in serum, plasma or whole blood. However, the use of BDNF as biomarker is limited by the poor reproducibility of results, likely due to the variety of methods used for sample collection and BDNF analysis. To overcome these limitations, using sera from 40 healthy adults, we compared the performance of five ELISA kits (Aviscera-Bioscience, Biosensis, Millipore-ChemiKine(TM), Promega-Emax(®), R&D-System-Quantikine(®)) and one multiplexing assay (Millipore-Milliplex(®)). All kits showed 100% sample recovery and comparable range. However, they exhibited very different inter-assay variations from 5% to 20%. Inter-assay variations were higher than those declared by the manufacturers with only one exception which also had the best overall performance. Dot-blot analysis revealed that two kits selectively recognize mature BDNF, while the others reacted with both pro-BDNF and mature BDNF. In conclusion, we identified two assays to obtain reliable measurements of human serum BDNF, suitable for future clinical applications.

Citing Articles

Circulating biomarkers and neuroanatomical brain structures differ in older adults with and without post-traumatic stress disorder.

Quigley B, Wellington N, Levenstein J, Dutton M, Boucas A, Forsyth G Sci Rep. 2025; 15(1):7176.

PMID: 40021745 PMC: 11871017. DOI: 10.1038/s41598-025-91840-0.


BDNF/BDNF-AS Gene Polymorphisms Modulate Treatment Response and Remission in Bipolar Disorder: A Randomized Clinical Trial.

Shkundin A, Wheeler H, Sinacore J, Halaris A J Pers Med. 2025; 15(2).

PMID: 39997339 PMC: 11856652. DOI: 10.3390/jpm15020062.


The BDNF-Interactive Model for Sustainable Hippocampal Neurogenesis in Humans: Synergistic Effects of Environmentally-Mediated Physical Activity, Cognitive Stimulation, and Mindfulness.

Khalil M Int J Mol Sci. 2024; 25(23).

PMID: 39684635 PMC: 11641763. DOI: 10.3390/ijms252312924.


Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.

Calder A, Hase A, Hasler G Mol Psychiatry. 2024; 30(2):763-776.

PMID: 39613915 PMC: 11753367. DOI: 10.1038/s41380-024-02830-z.


Environmental Affordance for Physical Activity, Neurosustainability, and Brain Health: Quantifying the Built Environment's Ability to Sustain BDNF Release by Reaching Metabolic Equivalents (METs).

Khalil M Brain Sci. 2024; 14(11).

PMID: 39595896 PMC: 11592236. DOI: 10.3390/brainsci14111133.


References
1.
Poste G . Bring on the biomarkers. Nature. 2011; 469(7329):156-7. DOI: 10.1038/469156a. View

2.
Monteleone P, Tortorella A, Martiadis V, Serritella C, Fuschino A, Maj M . Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med. 2004; 66(5):744-8. DOI: 10.1097/01.psy.0000138119.12956.99. View

3.
Huang E, Reichardt L . Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677-736. PMC: 2758233. DOI: 10.1146/annurev.neuro.24.1.677. View

4.
Lotrich F, Albusaysi S, Ferrell R . Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology. 2013; 38(6):985-95. PMC: 3629388. DOI: 10.1038/npp.2012.263. View

5.
Garcia K, Yu G, Nicolini C, Michalski B, Garzon D, Chiu V . Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism. J Neuropathol Exp Neurol. 2012; 71(4):289-97. PMC: 3419254. DOI: 10.1097/NEN.0b013e31824b27e4. View